21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013
Crossref DOI link: https://doi.org/10.1007/s10549-016-3926-5
Published Online: 2016-08-09
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Parsons, Benjamin M.
Landercasper, Jeffrey
Smith, Angela L.
Go, Ronald S.
Borgert, Andrew J.
Dietrich, Leah L.
License valid from 2016-08-09